Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APALUTAMIDE for Prostate cancer metastatic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 659 adverse event reports in the FDA FAERS database where APALUTAMIDE was used for Prostate cancer metastatic.

Most Reported Side Effects for APALUTAMIDE

Side Effect Reports % Deaths Hosp.
Rash 1,117 11.7% 47 225
Death 1,008 10.6% 991 45
Fatigue 824 8.6% 21 106
Hot flush 532 5.6% 12 61
Product dose omission issue 384 4.0% 1 24
Diarrhoea 317 3.3% 6 64
Asthenia 303 3.2% 13 67
Dizziness 294 3.1% 7 38
Fall 268 2.8% 20 133
Off label use 257 2.7% 32 44
Decreased appetite 255 2.7% 17 83
Arthralgia 253 2.7% 3 36
Prostatic specific antigen increased 251 2.6% 11 37
Pruritus 224 2.4% 5 59
Hospitalisation 209 2.2% 5 202

Other Indications for APALUTAMIDE

Product used for unknown indication (4,070) Prostate cancer (3,286) Hormone-dependent prostate cancer (533) Hormone-refractory prostate cancer (365) Neoplasm malignant (48) Prostate cancer stage 0 (25) Metastases to bone (17) Neoplasm prostate (17) Prostate cancer stage iv (13) Prostatic specific antigen increased (11)

Other Drugs Used for Prostate cancer metastatic

ABIRATERONE (3,535) ENZALUTAMIDE (3,171) SIPULEUCEL-T (2,563) LEUPROLIDE (1,109) DOCETAXEL (1,102) PREDNISONE (1,082) DENOSUMAB (575) CABAZITAXEL (451) RADIUM RA-223 DICHLORIDE (445) ZOLEDRONIC ACID (410)

Related Pages

APALUTAMIDE Full Profile All Prostate cancer metastatic Drugs APALUTAMIDE Demographics APALUTAMIDE Timeline